glp-1 cardiovascular outcomes trial august 2025 Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: effects in people with diabetes and cardiovascular disease | Cardiovascular Diabetology glp-1 cardiovascular outcomes trial august

Notably, no single GLP-1RA was superior to the others in preserving lean mass

If not, who decides our formulary?" Make the business case: Obesity treatment reduces long-term healthcare costs (diabetes, heart disease, joint problems) Gather support: If coworkers also want coverage, a group request carries more weight Time it right: Benefits are often reviewed in Q3-Q4 for the following year Be patient: Formulary changes typically take effect at the next plan year FOR PLANS THAT COVER ZEPBOUND Prior Authorization Requirements Prior Authorization Requirements Who These Requirements Apply To From October 1, 2026, Zepbound is a preferred option again on standard Aetna/CVS Caremark commercial plans, so these prior-authorization requirements apply broadly

Comprising the top executives from the areas foremost hospitals, the council includes Ralph Turner, president of Wellstar MCG Health Medical Center

Taura et al

Establish regular monitoring with your healthcare team